amgen said it has started preparing for a 50-million offering of subordinated convertible debentures to investors overseas mainly in europe a convertible debenture is an unsecured bond that ultimately may be exchanged for stock in a company amgen a thousand oaks biotechnology company is being assisted in preparing the offering by morgan stanley international earlier this month the u s food and drug administration approved the sale of amgen's biotechnology drug erythropoietin a long-awaited protein that treats chronic anemia in patients with kidney disease